A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes - Bretzel,R.G.; Arnolds,S.; Medding,J.; Linn,T. (Diabetes Care, 2004)